Advertisements

Liometacen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Liometacen

Property Description
Active Ingredients Indometacin, Lidocaine, Rutoside
Form Gel (Topical Formulation)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID) and Analgesic Combination
Common Use Localized relief of pain, inflammation, and swelling
Origin Synthetic Compound

What Type of Medicine is Liometacen? (Classification and Identity)

Liometacen is fundamentally a multi-component preparation classified as an Anti-inflammatory and Analgesic Combination, designed exclusively for external application to the skin. The drug is a synthetic compound that combines three distinct active substances to address localized discomfort. Its pharmacological identity is established by Indometacin, a recognized agent belonging to the Nonsteroidal Anti-inflammatory Drug (NSAID) class, which provides the primary anti-inflammatory action. This formulation is differentiated from typical single-ingredient NSAID topical preparations by its comprehensive scope, integrating anti-inflammatory action with two additional modes of symptom management.

Composition of the Liometacen Gel (Active Ingredients and Form)

The dosage form of Liometacen is a specialized gel for external use, utilizing a hydrophilic gel base to ensure effective delivery of its three active ingredients to the application site. These core components are Indometacin, an indole-acetic acid derivative; Lidocaine (Lignocaine), an amide-type local anesthetic that provides temporary numbing; and Rutoside (Rutosidum), a flavonoid derivative known for its venoprotective action. Rutoside is used for its ability to reduce symptoms associated with compromised vascular integrity. This specific triple-action composition targets inflammation, nerve pain, and capillary fragility, a unique differentiation feature of this combination drug.

General Benefit and Purpose (High-Level Action)

The general purpose of Liometacen is to provide comprehensive, localized symptomatic relief by mitigating discomfort associated with inflammatory processes near the skin surface. This combination product is designed to address three essential therapeutic targets simultaneously: reduction of underlying inflammation, immediate pain relief, and the lessening of localized swelling. For example, in situations involving superficial muscular strain or joint tenderness, this coordinated triple action provides the overall general benefit of alleviating pain and localized edema, supporting recovery without the need for systemic medication.

Advertisements

What side effects are possible with Liometacen?

Possible Side Effects and Safety Information

The safety profile for Liometacen Gel, a topical formulation containing Indometacin, Lidocaine, and Rutoside, is based on the classification of adverse reactions documented in official government regulatory labels. Given the topical application, the adverse reactions are primarily localized to the skin.


Officially Documented Adverse Reactions

The most Common to Uncommon adverse effects are dermatological and localized to the application site, including erythema (redness), pruritus (itching), rash, and a burning sensation. These reactions are generally classified within the Skin and Subcutaneous Tissue Disorders system-organ class.

Rare to Very Rare but serious adverse reactions documented in regulatory sources include severe systemic hypersensitivity reactions, such as anaphylactic shock or angioedema (swelling beneath the skin). Severe reactions necessitate immediate cessation of use, as documented in the product information.


Safety Considerations and Restrictions

The potential for systemic absorption of the active components is a key safety consideration. This risk is noted to increase with prolonged use or when the gel is applied over large skin areas or to compromised skin (e.g., open wounds or infected areas). The systemic risk requires caution in patients with a history of gastrointestinal ulceration, severe renal or hepatic impairment, or severe heart failure.

Official labels strictly contraindicate the use of this gel in individuals with a known history of NSAID-induced allergic reactions, such as asthma, urticaria, or rhinitis, following treatment with aspirin or other Nonsteroidal Anti-inflammatory Drugs. Furthermore, use is generally not recommended in the pediatric population due to limited data and safety concerns related to systemic exposure.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for a Liometacen overdose focuses on the risks associated with excessive systemic absorption of its active components, Indometacin (an NSAID) and Lidocaine (a local anesthetic). Documented clinical manifestations of overdose include gastrointestinal effects such as nausea, vomiting (potentially bloody), stomach pain, and diarrhea. Central Nervous System (CNS) effects noted are headache, confusion, agitation, and slurred speech.

Regulators document several severe or life-threatening outcomes requiring urgent attention. These include major CNS events like seizures and coma, severe cardiovascular issues such as cardiac arrest and arrhythmias, and organ damage like acute kidney injury or internal bleeding. Furthermore, a severe complication of local anesthetic exposure is the potential for Methemoglobinemia, particularly documented in infants and young children.

In any suspected overdose situation, regulatory guidance mandates that a person seek immediate medical help by contacting local emergency services or a Poison Control Center right away. Treatment, as officially described, centers on symptomatic and supportive measures, which may include procedures such as administering activated charcoal, gastric lavage, and continuous monitoring of vital signs and cardiac function (ECG).

Advertisements

Therapeutic Uses of Liometacen

Liometacen is commonly used to help with symptoms related to physical discomfort, including pain, swelling, and stiffness in certain inflammatory and musculoskeletal conditions. Specifically, it is utilized for supportive management of conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute painful shoulder, and acute gouty arthritis.


Easing Symptomatic Discomfort and Interference

Liometacen is applied in situations where symptoms create noticeable interference with daily stability or cause heightened patient distress. It provides support that contributes to easing the overall symptom load, and helps improve day-to-day comfort during periods of heightened symptoms.

“This medication helps address symptom clusters that may become intense or disruptive.”


Supporting Management of Episodic Symptom Clusters

This medication is commonly used across conditions characterized by episodic or fluctuating symptom patterns, or when symptom clusters require supportive management. It offers symptomatic relief that may help patients cope more steadily with symptom fluctuations and temporary functional strain or discomfort.

Quick Fact: Supports Management of Symptoms Linked to Irritative States


Relief for Acute Symptom Intensification

Liometacen is relevant in clinical settings marked by the sudden appearance or intensification of symptoms, often during phases where the patient experiences heightened discomfort. It is considered relevant when supportive symptom management is appropriate and symptoms become momentarily overwhelming.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Liometacen?

The official regulatory profile for Liometacen (Indometacin, Lidocaine, Rutoside topical gel) strictly defines eligibility based on a patient’s medical history, age, and physiological status, consistent with its Nonsteroidal Anti-inflammatory Drug (NSAID) component, Indometacin.

Absolute Contraindications

Liometacen is contraindicated and must not be used by specific populations:

  • Hypersensitivity: Patients with known allergy to Indometacin, any other component, or a history of allergic reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs.
  • Reproductive Status: Pregnant women starting at 30 weeks gestation (third trimester) and breastfeeding women due to documented NSAID risks.
  • Pediatric Use: Children younger than 14 years of age, as safety and efficacy in this group are not established or the product is contraindicated.
  • Application Site: The gel must not be applied to open wounds, mucous membranes, or severely damaged skin.

Conditional Use and Restrictions

Use is restricted or requires special consideration in certain populations:

  • Geriatric Patients: Use in the elderly requires greater care due to increased susceptibility to potential adverse reactions.
  • Organ Function: Caution is required for patients with pre-existing renal impairment, hepatic impairment, cardiac insufficiency, or hypertension.
Advertisements

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Liometacen based on the documented systemic risks of its active components, Indometacin and Lidocaine.

Pharmacodynamic and Bleeding Risks

The Indometacin component carries the interaction risks typical of a Nonsteroidal Anti-inflammatory Drug (NSAID). Co-administration with analgesic doses of aspirin or other NSAIDs is not generally recommended due to an increased risk of gastrointestinal adverse events, including bleeding. Indometacin may also diminish the antihypertensive or diuretic effects of Antihypertensive Agents such as ACE Inhibitors and ARBs.

Exposure Modification

Pharmacokinetic interactions documented in regulatory materials show that Indometacin can increase the serum concentration and prolong the half-life of Digoxin and Lithium salts, increasing the risk of toxicity for those co-administered medicines. The Lidocaine component's exposure (AUC/Cmax) may be increased by co-administration with strong CYP3A4/CYP1A2 enzyme inhibitors.

Additive Toxicity and Constraints

The Lidocaine component introduces risks of additive toxicity when co-administered with other local anesthetics or with specific methemoglobin-inducing agents. A condition-based interaction constraint is documented: the application of external heat sources to the area of application can increase the systemic absorption of Lidocaine. Population-specific cautions exist for the Indometacin component, noting an increased risk of renal deterioration when co-administered with ACE Inhibitors/ARBs in the elderly, volume depleted, or those with renal impairment.

Advertisements

Mechanism of Action

Blocking Prostaglandin Synthesis at the Source

Liometacen functions as a non-selective competitive inhibitor that targets the Cyclooxygenase enzymes, specifically both COX-1 and COX-2. This interaction occurs at the active site of the enzyme, thereby preventing the conversion of the substrate, arachidonic acid, into intermediary and final prostaglandins. The mechanism also includes inhibition of Phospholipase A2, which reduces the availability of arachidonic acid itself.


Modulating Signal Cascades and Thermoregulation

This reduction in prostaglandin production initiates a cascade that alters signal transduction across multiple systems. The mechanism involves the suppression of chemical mediators that promote local sensitization of peripheral nociceptors and the modulation of the central thermoregulatory set point within the hypothalamus. This combination of peripheral and central action results in the suppression of nociceptive signaling and the initiation of the reversal of elevated core body temperature.

Advertisements

Dosage and Administration Information

The Liometacen preparation is officially designated as a Gel for external use, mandating the Topical route of administration to the skin surface. This administration method dictates that the gel must be applied directly to the affected local area.


The standard administration pattern involves application multiple times daily in divided doses, utilizing a consistent schedule for localized symptomatic relief. The official regimen requires applying a thin layer of the gel, an amount that is sufficient to cover the localized site of discomfort without excessive buildup. The entire therapeutic course is generally restricted to a short-term duration consistent with the management of acute episodes.


Procedural Structure

Procedural adherence is critical for proper use. Before initiating the application, hands should be washed thoroughly with soap and water. The gel must be applied exclusively to intact skin, and application over broken, wounded, or irritated surfaces is restricted. Furthermore, the gel is strictly for external use, and contact must be prevented with mucous membranes and the eyes. Following the application procedure, immediate hand washing is required to conclude the administration. No explicit, labeled dose adjustments based on age or systemic organ function are published for this specific topical administration type.


This usage protocol establishes a non-systemic delivery method where the entire process—from initial hygiene to site restriction—is structured to ensure precise, localized application over a temporary, defined course.

Advertisements

Recent Clinical Evidence

Liometacen: Recent Clinical Evidence

The clinical understanding of the Liometacen topical gel is built upon the body of research concerning its primary anti-inflammatory component, Indometacin (a Nonsteroidal Anti-inflammatory Drug, or NSAID), as well as the general evidence base for multi-component topical pain treatments. This research describes what has been observed so far in specific patient groups and what remains unclear about the combination of Indometacin, Lidocaine, and Rutoside.


Clinical Research for Localized Musculoskeletal Discomfort

Research has explored this class of topical medicine for two main scenarios: acute soft tissue injuries (like sprains and strains) and localized symptoms of chronic conditions (like osteoarthritis). The evidence is primarily derived from Randomized Controlled Trials (RCTs) and systematic reviews that evaluated the active components.

For acute injuries, short-term RCTs, mainly conducted on adults, monitored outcomes related to localized pain intensity and functional movement. Findings describe patterns observed in measured changes when compared to placebo, but follow-up durations were limited, typically restricted to two weeks.

For chronic symptoms, research explored intermediate-term applications (up to 12 weeks). These studies focused on older adult populations and monitored metrics related to chronic pain scores and objective assessments of physical functional capacity. The evidence level for the topical NSAID component in this context is often described as Moderate, reflecting the existing research base.


Research Gaps and Areas of Uncertainty

A significant limitation noted in the overall evidence landscape is the limited information available for the specific triple-active combination of Indometacin, Lidocaine, and Rutoside. Specific data on the distinct contribution of the Lidocaine (pain relief) and Rutoside components to the overall outcomes is not always clearly isolated.

Furthermore, long-term effects are not fully established, as the follow-up durations of most high-quality trials are restricted to short or intermediate periods. Data for certain groups, such as pediatric populations or those with specific comorbidities, also remain insufficient.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Liometacen (FAQ)


Q: Is Liometacen safe for use in older adults?

Regulatory documents note that greater care is indicated for use in older adults due to their increased susceptibility to potential side effects. The NSAID component of the gel carries an increased risk of specific adverse effects, particularly related to kidney function, in elderly patients who may have pre-existing health conditions or fluid loss.

Q: Does Liometacen affect blood pressure?

Official drug information for the NSAID class, which includes a component of Liometacen, notes that these medicines can potentially lead to new onset of high blood pressure or worsen existing high blood pressure. Additionally, regulatory documents indicate this component may diminish the effects of certain medications used to manage high blood pressure.

Q: Are headaches a common side effect of Liometacen?

The official product information for the topical gel primarily lists localized skin reactions as common side effects. However, the systemic NSAID component (Indometacin) can commonly cause effects like headache or dizziness when taken orally. The reported risk for the topical gel is related to the amount of medicine absorbed into the body.

Q: Is it safe to drive or operate machinery while taking Liometacen?

Since the medicine is applied topically, it is generally considered to have a localized effect. However, due to the risk of the active ingredients being absorbed into the body, the official label for the NSAID component notes potential Central Nervous System (CNS) effects, such as dizziness or drowsiness. Official information notes that if systemic absorption occurs, patients may experience effects; awareness of potential impacts before engaging in activities like driving is generally mentioned in drug labels.

Q: Can I stop taking Liometacen suddenly?

Official guidelines recommend using the lowest effective dose for the shortest duration necessary for treatment. Since Liometacen is generally prescribed for short-term management of acute conditions, cessation is often planned once the symptoms of inflammation and pain have been controlled. Cessation instructions are typically provided by a healthcare provider, as they are based on the patient’s specific condition and treatment goals.

Q: How quickly can someone expect to feel the effects of Liometacen?

The product contains two components that affect pain: a local anesthetic (Lidocaine) and an anti-inflammatory drug (Indometacin). The local anesthetic provides temporary numbing, which may be felt quickly. The full benefit of the anti-inflammatory effect on the underlying condition may take slightly longer, requiring consistent application over several days as part of the short-term treatment course.

Q: Is the effect of Liometacen on a condition immediate or does it build up over time?

The effect is two-fold. The local anesthetic ingredient provides a more immediate, temporary numbing sensation. Meanwhile, the anti-inflammatory ingredient works to reduce the underlying inflammation over time, meaning the full therapeutic benefit may build up over the short course of treatment.

Q: Does Liometacen cause weight gain or loss?

Official drug information for the NSAID class notes that one potential side effect is fluid retention, known as edema. This condition, fluid retention, may result in an increase in body weight. There are no direct claims or warnings in regulatory documents about Liometacen causing weight loss.

Q: Can Liometacen affect my mood or sleep?

Systemic use of the NSAID component is sometimes associated with effects on the Central Nervous System (CNS), including drowsiness, dizziness, or, rarely, changes in mood. These effects are considered possible if the active ingredients from the topical gel are absorbed into the body.

Q: How long does Liometacen stay in the body after the last dose?

The time it takes for a drug to clear the body is related to its half-life. Official documents indicate that the half-life of the primary component, Indometacin, is typically several hours for systemic formulations. The time it takes to fully clear the body is influenced by this half-life and the amount of systemic absorption from topical use.

Q: Are the side effects of Liometacen permanent?

Most common side effects, such as localized skin issues (redness or itching), are temporary and generally expected to resolve once the use of the medicine is stopped. In the rare event of severe systemic reactions, official labels state that the medication should be stopped and prompt medical care is needed.

Q: Can Liometacen be used for chronic pain relief?

Official guidelines and clinical research describe the use of this class of medicine for short-term treatment of acute soft tissue injuries and for localized symptoms of chronic conditions. The duration of use is typically limited to short or intermediate periods, such as up to 12 weeks in some studies, adhering to the principle of using the lowest effective dose for the shortest duration.

Q: Will taking Liometacen affect the results of blood tests?

The potential for systemic absorption means the NSAID component carries risks that may require laboratory monitoring, specifically of liver and kidney function tests, in certain susceptible patients. Official documents also mention potential changes in other laboratory values, such as blood cell counts.

Q: What is the typical duration of treatment with Liometacen?

The entire course of therapy is generally restricted to a short-term duration that is necessary to manage acute symptoms. Treatment duration for topical NSAID applications is often limited to a specific time frame, such as 7 to 14 days, depending on the condition being treated and the official local guidelines.

Q: Are there different strengths or forms of Liometacen available?

Official product documents define Liometacen as a specific Gel for external use containing the three active ingredients (Indometacin, Lidocaine, Rutoside) at defined concentrations. Any other strengths or pharmaceutical forms would be explicitly listed in the regulatory documents if they were authorized for use.

Q: Why does Liometacen sometimes cause a dry mouth?

Dry mouth has been reported as an uncommon side effect associated with the systemic use of the NSAID component. Since the gel's active ingredients can be absorbed into the body, there is a possibility for this effect to occur.

Q: How often do people report feeling dizzy or lightheaded while on Liometacen?

While localized skin reactions are the most common adverse events for the gel, dizziness and lightheadedness are common effects reported for the systemic (oral) administration of the NSAID component. The reported frequency of these reactions with the topical gel relates directly to the amount of active ingredient absorbed through the skin.

Q: Does Liometacen interact with alcohol?

The NSAID component of Liometacen is known to carry an increased risk of gastrointestinal adverse events, including bleeding, when combined with alcohol. Regulatory bodies often note that the use of NSAIDs, even topically, is associated with a need to avoid or limit alcohol consumption due to this potentially enhanced risk.

Q: What is the purpose of the black box warning on Liometacen?

The NSAID class of drugs, including the active ingredient Indometacin, carries a Boxed Warning (often called a 'black box warning') in regulatory documents. This warning addresses the potential for serious cardiovascular risks, such as heart attack or stroke, and serious gastrointestinal risks, such as bleeding and perforation. The warning exists because of the potential for systemic risks associated with the NSAID component.

Q: Does taking Liometacen affect fertility? (Informational only)

The NSAID class of drugs is associated with a potential for reversible impairment of female fertility, which is noted in official documentation. This is a class warning that is typically considered by women who are actively trying to conceive.

Q: Can Liometacen cause sensitivity to sunlight?

Photosensitivity, or an uncommon sensitivity to sunlight, has been reported in association with the NSAID component of the drug. Official documents mention that exposure to direct sunlight or sunlamps may require consideration during the use of the gel.

Q: What are the signs of an accidental overdose of Liometacen?

Symptoms of an overdose are related to the systemic effects of the active components. Overdose of the NSAID component may result in signs like severe headache, nausea, vomiting, or drowsiness. Overdose of the local anesthetic component may cause symptoms such as dizziness or blurred vision. Systemic toxicity depends on the amount absorbed.

Advertisements

How should Liometacen be stored and disposed of?

Liometacen Gel must be stored and disposed of according to strict official guidelines to ensure product integrity and public safety.

Storage Conditions

The product must be kept at room temperature, typically between 20 C and 25 C. The gel must be protected from direct light and stored away from heat and freezing to maintain its stability. The original container must be kept tightly closed at all times.

Handling and Disposal

All medicines, including Liometacen Gel, must be stored out of the sight and reach of children.

For disposal, follow any specific instructions provided with the medicine. If no instructions are available, return the unused or expired gel to a drug take-back program. If a take-back option is unavailable, the gel must be mixed with an undesirable substance (e.g., used coffee grounds) and sealed in a container before placing it in the trash. Do not flush the gel down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Liometacen found in:

A-Z Index: